The growing role of PARP inhibitors in the treatment of metastatic castration-resistant prostate cancer

Transl Cancer Res. 2023 Dec 31;12(12):3233-3240. doi: 10.21037/tcr-23-1515. Epub 2023 Nov 13.

Authors

John Panzone¹, Gavrielle J Rood¹, Hanan Goldberg¹

Affiliation

¹ Department of Urology, SUNY Upstate Medical University, Syracuse, NY, USA.

No abstract available

Keywords: Prostate cancer; castration-resistant; germline mutations; poly (ADP-ribose) polymerase inhibitors (PARPis).

Publication types

Editorial
Comment